COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 2805: Articles 28041-28050  | Next

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Brouwer, P., Caniels, T., van Straten, K., Snitselaar, J., Aldon, Y., Bangaru, S., Torres, J., Okba, N., Claireaux, M., Kerster, G., Bentlage, A., van Haaren, M., Guerra, D., Burger, J., Schermer, E., Verheul, K., van der Velde, N., van der Kooi, A., van Schooten, J., van Breemen, M., Bijl, T., Sliepen, K., Aartse, A., Derking, R., Bontjer, I., Kootstra, N., Wiersinga, J., Vidarsson, G., Haagmans, B., Ward, A., de Bree, G., Sanders, R., van Gils, M.
10.1101/2020.05.12.088716 — Posted: 2020-05-12
Antiviral options against SARS-CoV-2 infection
Ianevski, A., Yao, R., Fenstad, M. H., Biza, S., Zusinaite, E., Lysvand, H., Loeseth, K., Lamndsem, V. M., Malmring, J. F., Oksenych, V., Erlandsen, S. E., Aas, P. A., Hagen, L., Pettersen, C. H., Afset, J. E., Nordbo, S. A., Bjoras, M., Kainov, D. E.
10.1101/2020.05.12.091165 — Posted: 2020-05-12
Performance of the rapid Nucleic Acid Amplification by Abbott ID NOW COVID-19 in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution
Basu, A., Zinger, T., Inglima, K., Woo, K.-m., Atie, O., Yurasits, L., See, B., Aguero-Rosenfeld, M. E.
10.1101/2020.05.11.089896 — Posted: 2020-05-12 Discussion: Onsite | Offsite
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual
Seydoux, E., Homad, L. J., MacCamy, A. J., Parks, K. R., Hurlburt, N. K., Jennewein, M. F., Akins, N. R., Stuart, A. B., Wan, Y.-H., Feng, J., Nelson, R., Singh, S., Cohen, K. W., McElrath, J. M., Englund, J. A., Chu, H. Y., Pancera, M., McGuire, A. T., Stamatatos, L.
10.1101/2020.05.12.091298 — Posted: 2020-05-12
A putative new SARS-CoV protein, 3a*, encoded in an ORF overlapping ORF3a
Firth, A. E.
10.1101/2020.05.12.088088 — Posted: 2020-05-12
The SARS-CoV-2 conserved macrodomain is a highly efficient ADP-ribosylhydrolase enzyme
Alhammad, Y. M. O., Kashipathy, M. M., Roy, A., Johnson, D. K., McDonald, P., Battaile, K. P., Gao, P., Lovell, S. W., Fehr, A. R.
10.1101/2020.05.11.089375 — Posted: 2020-05-12
Local computational methods to improve the interpretability and analysis of cryo-EM maps
Kaur, S., Gomez-Blanco, J., Adinarayanan, S., Khalifa, A., Sanchez-Garcia, R., Wrapp, D., McLellan, J. S., Bui, K. H., Vargas, J.
10.1101/2020.05.11.088013 — Posted: 2020-05-12
Pericyte-specific vascular expression of SARS-CoV-2 receptor ACE2 - implications for microvascular inflammation and hypercoagulopathy in COVID-19 patients
He, L., Mae, M. A., Sun, Y., Muhl, L., Nahar, K., Liebanas, E. V., Fagerlund, M. J., Oldner, A., Liu, J., Genove, G., Pietila, R., Zhang, L., Xie, Y., Liptidis, S., Mocci, G., Stritt, S., Osman, A., Anisimov, A., Hemanthakumar, K. A., Rasenen, M., Bjorkegren, J., Vanlandewijck, M., Blomgren, K., Hansson, E., Makinen, T., Peng, X.-R., Arnold, T. D., Alitalo, K., Eriksson, L. I., Lendahl, U., Betsholtz, C.
10.1101/2020.05.11.088500 — Posted: 2020-05-12 Discussion: Onsite
Placental pathology in COVID-19
Shanes, E. D., Mithal, L. B., Otero, S., Azad, H. A., Miller, E. S., Goldstein, J. A.
10.1101/2020.05.08.20093229 — Posted: 2020-05-12
Using epidemic simulators for monitoring an ongoing epidemic
Raghavan, M., Sridharan, K. S., M R, Y.
10.1101/2020.05.08.20095463 — Posted: 2020-05-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).